Inhibrx Biosciences, Inc. Common Stock
INBX
$108.65
-14.84%
INBX
Inhibrx Biosciences, Inc. Common Stock
$108.65
INBX price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Inhibrx Biosciences, Inc. Common Stock's 12-month outlook, with a consensus price target around $141.25 and implied upside of +30.0% versus the current price.
Average Target
$141.25
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$87 - $141
Analyst target range
INBX Technical Analysis
Beta
—
—
Max Drawdown
-37.6%
Largest decline past year
52-Week Range
$11-$155
Price range past year
Annual Return
+827.8%
Cumulative gain past year
| Period | INBX Return | S&P 500 |
|---|---|---|
| 1m | +44.3% | +8.6% |
| 3m | +32.5% | +6.7% |
| 6m | +45.6% | +9.8% |
| 1y | +827.8% | +26.6% |
| ytd | +44.8% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is INBX Overvalued?
PE
-8.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-9.1x
Enterprise Value Multiple
